Delving into the Latest Updates on Gedeon Richter Pharma GmbH with Synapse

Overview

Tags

Immune System Diseases

Skin and Musculoskeletal Diseases

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	3

Top 5 Target	Count

ACE x L-type calcium channel	1
COX(Cyclooxygenases)	1
H3 receptor(Histamine H3 receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

2

Approved

Other

20

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Aceclofenac ( COX )	Rheumatoid Arthritis More	Approved
Amlodipine Besylate/Lisinopril ( ACE x L-type calcium channel )	Hypertension More	Approved
H3 receptor antagonists(Gedeon Richter Pharma) ( H3 receptor )	-	Preclinical
RGH-478 ( B1 receptor )	Osteoarthritis More	Discontinued
Vintoperol ( VDCCs x α-adrenergic receptor )	Peripheral Vascular Diseases More	Discontinued